Kevin H. Rhodes
Known title: EVP, Chief Legal Off & SecretCIK: 0001901300
Associated companies
Transaction History
| MMM | ▲ Buy | Option Exercise | 176 | $29K | 10/7/2026 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 176 | $29K | 10/7/2026 | View on chart |
| MMM | ▲ Buy | Option Exercise | 7,669 | $1.2M | 7/22/2026 | View on chart |
| MMM | ▼ Sell | Open Market | 7,669 | $1.3M | 7/22/2026 | View on chart |
| MMM | ▲ Buy | Option Exercise | 17,904 | $3.1M | 2/6/2026 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 6,915 | $1.2M | 2/6/2026 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 4,732 | $0 | 2/2/2026 | View on chart |
| MMM | ▲ Buy | Grant | 23,251 | $0 | 2/2/2026 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 203 | $32K | 10/1/2025 | View on chart |
| MMM | ▲ Buy | Option Exercise | 203 | — | 10/1/2025 | View on chart |
| MMM | ▲ Buy | Option Exercise | 7,976 | $1.0M | 5/20/2025 | View on chart |
| MMM | ▼ Sell | Open Market | 7,976 | $1.2M | 5/20/2025 | View on chart |
| MMM | ▲ Buy | Option Exercise | 9,135 | $1.4M | 2/7/2025 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 2,951 | $442K | 2/7/2025 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 1,239 | $0 | 2/3/2025 | View on chart |
| MMM | ▲ Buy | Grant | 5,162 | $0 | 2/3/2025 | View on chart |
| MMM | ▲ Buy | Option Exercise | 6,850 | $1.0M | 1/27/2025 | View on chart |
| MMM | ▼ Sell | Open Market | 6,743 | $1.0M | 1/27/2025 | View on chart |
| MMM | ▲ Buy | Option Exercise | 579 | — | 10/16/2024 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 579 | $79K | 10/16/2024 | View on chart |
| MMM | ▲ Buy | Grant | 715 | $0 | 2/5/2024 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 157 | $0 | 2/5/2024 | View on chart |
| MMM | ▲ Buy | Option Exercise | 414 | $39K | 2/2/2024 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 117 | $11K | 2/2/2024 | View on chart |
| MMM | ▲ Buy | Option Exercise | 535 | — | 10/4/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 535 | $47K | 10/4/2023 | View on chart |
| MMM | ▲ Buy | Grant | 1,153 | $0 | 2/6/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 328 | $0 | 2/6/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 86 | $10K | 2/3/2023 | View on chart |
| MMM | ▲ Buy | Option Exercise | 168 | $20K | 2/3/2023 | View on chart |
| MMM | ▼ Sell | Open Market | 1,269 | $160K | 10/28/2022 | View on chart |
| MMM | ▼ Sell | Open Market | 600 | $76K | 10/28/2022 | View on chart |
| MMM | ▼ Sell | Open Market | 100 | $13K | 10/28/2022 | View on chart |
| MMM | ▼ Sell | Open Market | 3,734 | $472K | 10/28/2022 | View on chart |
| MMM | ▲ Buy | Option Exercise | 5,703 | $579K | 10/28/2022 | View on chart |
| MMM | ▲ Buy | Option Exercise | 273 | — | 10/5/2022 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 273 | $31K | 10/5/2022 | View on chart |
| MMM | ▲ Buy | Grant | 766 | $0 | 2/7/2022 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 201 | $0 | 2/7/2022 | View on chart |
| MMM | ▲ Buy | Option Exercise | 167 | $27K | 2/4/2022 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 73 | $12K | 2/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.